SKYFAME REALTY (00059) receives additional resumption guidance from the Stock Exchange and continues to remain suspended.
Tianyu Property Co., Ltd. (00059) announced that on December 2, 2025, the company received a letter from the Stock Exchange, which included additional resumption guidelines for the resumption of trading of the company's shares on the Stock Exchange: The winding-up order against the company has been withdrawn or revoked, and the appointment of any liquidator has been revoked. The company's shares remain suspended from trading.
Skyfame Realty (00059) announced that on December 2, 2025, the company received a letter from the Stock Exchange, which included additional resumption guidelines for the resumption of trading of the company's shares on the Stock Exchange: The winding-up order of the company has been withdrawn or revoked, and any liquidator's appointment has been revoked. The company's shares will continue to be suspended from trading.
Related Articles
HAOHAI BIOTEC (06826) spent 837,000 Hong Kong dollars to repurchase 30,500 shares on December 5th.
The controlling shareholder of KONTA CHINA (01312) remains unchanged. Shanxi Construction Investment holds 52.44% of the shares and Shanxi Communications holds 90% of the shares have been transferred to the Shanxi Provincial State-owned Assets Supervision and Administration Commission.
CSPC PHARMA (01093): GLP-1/GIP receptor biased agonist dual peptide injection approved for clinical trials in the United States.
HAOHAI BIOTEC (06826) spent 837,000 Hong Kong dollars to repurchase 30,500 shares on December 5th.
The controlling shareholder of KONTA CHINA (01312) remains unchanged. Shanxi Construction Investment holds 52.44% of the shares and Shanxi Communications holds 90% of the shares have been transferred to the Shanxi Provincial State-owned Assets Supervision and Administration Commission.
CSPC PHARMA (01093): GLP-1/GIP receptor biased agonist dual peptide injection approved for clinical trials in the United States.
